These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32555115)

  • 1. Talicia - a 3-drug combination for Helicobacter pylori infection.
    Med Lett Drugs Ther; 2020 Jun; 62(1599):83-85. PubMed ID: 32555115
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.
    Gisbert JP; Barrio J; Modolell I; Molina-Infante J; Aisa AP; Castro-Fernández M; Rodrigo L; Cosme A; Gisbert JL; Fernández-Bermejo M; Marcos S; Marín AC; McNicholl AG
    Dig Dis Sci; 2015 Feb; 60(2):458-64. PubMed ID: 25236423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice.
    Zullo A; De Francesco V; Manes G; Scaccianoce G; Cristofari F; Hassan C
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):131-4. PubMed ID: 20593044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two vonoprazan combinations (Voquezna) for H. pylori.
    Med Lett Drugs Ther; 2022 Oct; 64(1662):169-172. PubMed ID: 36383768
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.
    Borody TJ; Pang G; Wettstein AR; Clancy R; Herdman K; Surace R; Llorente R; Ng C
    Aliment Pharmacol Ther; 2006 Feb; 23(4):481-8. PubMed ID: 16441468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifabutin-based high-dose proton-pump inhibitor and amoxicillin triple regimen as the rescue treatment for Helicobacter pylori.
    Lim HC; Lee YJ; An B; Lee SW; Lee YC; Moon BS
    Helicobacter; 2014 Dec; 19(6):455-61. PubMed ID: 25231089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
    Zullo A; Scaccianoce G; De Francesco V; Ruggiero V; D'Ambrosio P; Castorani L; Bonfrate L; Vannella L; Hassan C; Portincasa P
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):647-50. PubMed ID: 23747131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bismuth + metronidazole + tetracycline. Why risk adding bismuth?
    Prescrire Int; 2013 Apr; 22(137):89-92. PubMed ID: 23662315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures.
    Gisbert JP; Calvet X; Bujanda L; Marcos S; Gisbert JL; Pajares JM
    Helicobacter; 2003 Apr; 8(2):90-4. PubMed ID: 12662375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.
    van Zanten SV; Desai S; Best L; Cooper-Lesins G; Malatjalian D; Haldane D; Peltekian K
    Can J Gastroenterol; 2010 May; 24(5):303-6. PubMed ID: 20485704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori.
    Fiorini G; Zullo A; Vakil N; Saracino IM; Ricci C; Castelli V; Gatta L; Vaira D
    J Clin Gastroenterol; 2018 Feb; 52(2):137-140. PubMed ID: 27136964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
    Peitz U; Sulliga M; Wolle K; Leodolter A; Von Arnim U; Kahl S; Stolte M; Börsch G; Labenz J; Malfertheiner P
    Aliment Pharmacol Ther; 2002 Feb; 16(2):315-24. PubMed ID: 11860415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
    Fiorini G; Zullo A; Saracino IM; Gatta L; Pavoni M; Vaira D
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):621-625. PubMed ID: 29481383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):921-6. PubMed ID: 11507356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifabutin triple therapy for first-line and rescue treatment of Helicobacter pylori infection: A systematic review and meta-analysis.
    Gingold-Belfer R; Niv Y; Levi Z; Boltin D
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1392-1402. PubMed ID: 33037845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile infection associated with bismuth-based quadruple therapy (Pylera
    Castro-Fernández M; Marqués-Ruiz A; Cámara-Baena S; Grande-Santamaría L
    Gastroenterol Hepatol; 2019; 42(7):459-460. PubMed ID: 30902506
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acid-related diseases. What is the current rescue treatment of choice for Helicobacter pylori: quadruple therapy (proton pump inhibitor, bismuth, tetracycline and metronidazole) or triple therapy with proton pump inhibitor, amoxicillin and levofloxacin?].
    Calvet X
    Gastroenterol Hepatol; 2008; 31(6):400-1. PubMed ID: 18570821
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study.
    Nseir W; Diab H; Mahamid M; Abu-Elheja O; Samara M; Abid A; Mograbi J
    Aliment Pharmacol Ther; 2012 Aug; 36(3):231-8. PubMed ID: 22646167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.